CA19|9 Reduction After 4 Months of Treatment Is a Prognostic ...

CA19-9 Reduction After 4 Months of Treatment Is a Prognostic ...

In conclusion, CA19-9 of less than 100 U/ml or a decrease of more than 70% from baseline at four months was a positive prognostic factor for chemotherapy in ...

CA19-9 Reduction After 4 Months of Treatment Is a Prognostic ...

CA19-9 values 4 months after commencing treatment are a significant prognostic factor in LAPC patients undergoing chemotherapy.

CA19-9 Reduction After 4 Months of Treatment Is a Prognostic ...

CA19-9 Reduction After 4 Months of Treatment Is a Prognostic Factor for Locally Advanced Pancreatic Cancer · Find this author on Google Scholar · Find this author ...

[PDF] CA19-9 Reduction After 4 Months of Treatment Is a Prognostic ...

CA19-9 values 4 months after commencing treatment are a significant prognostic factor in LAPC patients undergoing chemotherapy, and are associated with a ...

Duration of Reduced CA19-9 Levels Is a Better Prognostic Factor ...

During 6 months after treatment, CA19-9 levels decreased for 71 patients, but improved OS was not observed in 64 (90%) of these patients who had RR-C >44% ( ...

CA19-9 Reduction After 4 Months of Treatment Is a Prognostic ...

Request PDF | CA19-9 Reduction After 4 Months of Treatment Is a Prognostic Factor for Locally Advanced Pancreatic Cancer | Background/aim: Carbohydrate ...

Change in CA 19-9 levels after chemoradiotherapy predicts survival ...

The median post-treatment CA 19-9 level for all patients was 293 U/mL and also exhibited prognostic significance. The median survival of patients with a CA 19-9 ...

CA19.9 decrease >15% is a predictor of favourable outcome in ...

Original article. CA19.9 decrease >15% is a predictor of favourable outcome in patients treated for advanced pancreatic carcinoma: analysis of two independent ...

Prognostic and predictive value of CA 19-9 in locally advanced ...

From the NEOLAP study population (N = 165) 133 patients (81%) were evaluable for CA 19-9 at baseline and 81/88 patients (92%) for post-ICT CA 19 ...

CA19-9 decrease at 8 weeks as a predictor of overall survival in a ...

This analysis demonstrated that, in patients with MPC, any CA19-9 decrease at week 8 can be an early marker for chemotherapy efficacy, including in those ...

Analysis of prognostic factors for borderline resectable pancreatic ...

In patients with pre-treatment CA19-9 >500 U/mL, the CA19-9 decrease ≤80% was strongly associated with poor survival and new strategy should be reconsidered for ...

CA19–9 decrease and survival according to platelet level in patients ...

CA19–9 decrease during treatment has been associated with superior survival of pancreatic cancer in several studies. The evidence to show ...

Prognostic value of CA 19-9 levels in patients with inoperable ...

Serum carbohydrate antigen 19-9 (CA 19-9) has been identified as a useful tumour marker for diagnosis of exocrine pancreatic carcinoma, ...

Serum CA19-9 response as a surrogate for clinical outcome in ...

CA19-9 responders, defined as those with a ⩾50% decrease in CA19-9 levels within 2 months after the start of treatment, survived significantly ...

(PDF) Duration of Reduced CA19-9 Levels Is a Better Prognostic ...

In patients with unresectable LAPC, the duration of reduced CA19-9 levels for more than 3 months, rather than the rate of reduction in CA19-9 ...

Decreased serum carbohydrate antigen 19–9 levels after ...

Decreased CA19–9 levels after neoadjuvant therapy predicts a better prognosis, with low incidence of hepatic recurrence after surgery.

The prognostic and predictive value of serum CA19.9 in pancreatic ...

9 at 3 months (median survival 25.6 vs 14.8 months, P = 0.0052) and before adjuvant chemotherapy were independent prognostic factors. Patients with ...

The clinical utility of serum CA 19-9 in the diagnosis, prognosis and ...

Patients with a higher percent decline in CA 19-9 serum level following treatment had improved overall survival (Group III-16.7 months compared to Group II-10 ...

Perioperative CA19-9 Levels Can Predict Stage and Survival in ...

CA19-9 levels should be included in a patient's perioperative care and should be considered for prognostic nomograms. Introduction. The majority ...

Prognostic and Therapeutic Significance of Carbohydrate Antigen ...

Also a CA 19-9 decline under chemotherapy can provide prognostic information for median survival. A 20% reduction of CA 19-9 baseline levels ...